Cardiac magnetic resonance markers of progressive RV dilation and dysfunction after tetralogy of Fallot repair

Heart

Volumn 101, Issue 21, 2015, Pages 1724-1730

  Wald, Rachel M ^a   Valente, Anne Marie ^b,c   Gauvreau, Kimberlee ^b,c   Babu Narayan, Sonya V ^d   Assenza, Gabriele Egidy ^b,c   Schreier, Jenna ^b,c   Gatzoulis, Michael A ^d   Kilner, Philip J ^d   Koyak, Zeliha ^e   Mulder, Barbara ^e   Powell, Andrew J ^b,c   Geva, Tal ^b,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DIASTOLIC DYSFUNCTION; DISEASE COURSE; DISEASE REGISTRY; ELECTROCARDIOGRAPHY; EXERCISE; FALLOT TETRALOGY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART RIGHT VENTRICLE DILATION; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE ENDDIASTOLIC VOLUME; HEART RIGHT VENTRICLE ENDSYSTOLIC VOLUME; HEART RIGHT VENTRICLE FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PREVALENCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ADVERSE EFFECTS; CARDIOVASCULAR SURGERY; CLINICAL TRIAL; ETIOLOGY; HEART FUNCTION TEST; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE; MULTICENTER STUDY; NETHERLANDS; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; PROCEDURES; REGISTER; RETROSPECTIVE STUDY; TETRALOGY OF FALLOT; UNITED KINGDOM; UNITED STATES;

ADULT; CARDIOVASCULAR SURGICAL PROCEDURES; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GREAT BRITAIN; HEART FUNCTION TESTS; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; NETHERLANDS; ORGAN SIZE; POSTOPERATIVE COMPLICATIONS; REGISTRIES; RETROSPECTIVE STUDIES; TETRALOGY OF FALLOT; UNITED STATES; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84947931925     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2015-308014     Document Type: Article

References (20)

1. Gatzoulis MA, Balaji S, Webber SA, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet 2000; 356: 975-81.
2. Valente AM, Gauvreau K, Assenza GE, et al. Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the indicator cohort. Heart 2014; 100: 247-53.
3. Silversides CK, Kiess M, Beauchesne L, et al. Canadian cardiovascular society 2009 consensus conference on the management of adults with congenital heart disease: outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfan's syndrome. Can J Cardiol 2010; 26: e80-97.
4. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Developed in collaboration with the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008; 52: e1-121.
5. Baumgartner H, Bonhoeffer P, De Groot NM, et al. Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of C, Association for European Paediatric C, Guidelines ESCCfP. ESC guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 2010; 31: 2915-57.
6. Valente AM, Cook S, Festa P, et al. Multimodality imaging guidelines for patients with repaired tetralogy of Fallot: a report from the American Society of Echocardiography: developed in collaboration with the society for cardiovascular magnetic resonance and the society for pediatric radiology. J Am Soc Echocardiogr 2014; 27: 111-41.
7. Quail MA, Frigiola A, Giardini A, et al. Impact of pulmonary valve replacement in tetralogy of Fallot with pulmonary regurgitation: a comparison of intervention and nonintervention. Ann Thorac Surg 2012; 94: 1619-26.
8. Spiewak M, Malek LA, Petryka J, et al. Stable right ventricular size and function during short-term follow-up in patients with pulmonary regurgitation after tetralogy of Fallot repair. Clin Radiol 2013; 68: 1206-11.
9. Luijnenburg SE, Helbing WA, Moelker A, et al. 5-year serial follow-up of clinical condition and ventricular function in patients after repair of tetralogy of Fallot. Int J Cardiol 2013; 169: 439-44.
10. Grothoff M, Hoffmann J, Lehmkuhl L, et al. Time course of right ventricular functional parameters after surgical correction of tetralogy of Fallot determined by cardiac magnetic resonance. Clin Res Cardiol 2011; 100: 343-50.
11. Valente AM, Gauvreau K, Assenza GE, et al. Rationale and design of an international multicenter registry of patients with repaired tetralogy of Fallot to define risk factors for late adverse outcomes: the indicator cohort. Pediatr Cardiol 2013; 34: 95-104.
12. Mooij CF, de Wit CJ, Graham DA, et al. Reproducibility of mri measurements of right ventricular size and function in patients with normal and dilated ventricles. J Magn Reson Imaging 2008; 28: 67-73.
13. Blalock SE, Banka P, Geva T, et al. Interstudy variability in cardiac magnetic resonance imaging measurements of ventricular volume, mass, and ejection fraction in repaired tetralogy of Fallot: a prospective observational study. J Magn Reson Imaging 2013; 38: 829-35.
14. Geva T. Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support. J Cardiovasc Magn Reson 2011; 13: 9.
15. Alfakih K, Plein S, Thiele H, et al. Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. J Magn Reson Imaging 2003; 17: 323-9.
16. Haycock GB, Schwartz GJ, Wisotsky DH. Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. J Pediatr 1978; 93: 62-6.
17. Geva T. Indications for pulmonary valve replacement in repaired tetralogy of Fallot: the quest continues. Circulation 2013; 128: 1855-7.
18. Wald RM, Altaha MA, Alvarez N, et al. Rationale and design of the Canadian outcomes registry late after tetralogy of Fallot repair: the correlate study. Can J Cardiol 2014; 30: 1436-43.
19. Babu-Narayan SV, Gatzoulis MA. Management of adults with operated tetralogy of Fallot. Curr Treatment Options Cardiovasc Med 2003; 5: 389-98.
20. Geva T. Is MRI the preferred method for evaluating right ventricular size and function in patients with congenital heart disease? MRI is the preferred method for evaluating right ventricular size and function in patients with congenital heart disease. Circ Cardiovasc Imaging 2014; 7: 190-7.